Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azarga vs Cosopt in Glaucoma or Ocular Hypertension
NCT01111890Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Apr 2010
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of brinzolamide in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoint: Mean change in Intraocular Pressure at 12 weeks. Started Apr 2010; status: completed.
02
Drugs
brinzolamide
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01111890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01111890.